Cargando…

DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer

SF3B1 is the most frequently mutated spliceosomal gene in cancer. Several hotspot mutations are known to disrupt the interaction of SF3B1 with another splicing factor, SUGP1, resulting in the RNA missplicing that characterizes mutant SF3B1 cancers. Properties of SUGP1, especially the presence of a G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Huang, Ji, Xu, Ke, Xing, Peiqi, Huang, Yue, Liu, Zhaoqi, Tong, Liang, Manley, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894173/
https://www.ncbi.nlm.nih.gov/pubmed/36459648
http://dx.doi.org/10.1073/pnas.2216712119
_version_ 1784881686691971072
author Zhang, Jian
Huang, Ji
Xu, Ke
Xing, Peiqi
Huang, Yue
Liu, Zhaoqi
Tong, Liang
Manley, James L.
author_facet Zhang, Jian
Huang, Ji
Xu, Ke
Xing, Peiqi
Huang, Yue
Liu, Zhaoqi
Tong, Liang
Manley, James L.
author_sort Zhang, Jian
collection PubMed
description SF3B1 is the most frequently mutated spliceosomal gene in cancer. Several hotspot mutations are known to disrupt the interaction of SF3B1 with another splicing factor, SUGP1, resulting in the RNA missplicing that characterizes mutant SF3B1 cancers. Properties of SUGP1, especially the presence of a G-patch motif, a structure known to function by activating DEAH-box RNA helicases, suggest the requirement of such an enzyme in SUGP1 function in splicing. However, the identity of this putative helicase has remained an important unanswered question. Here, using a variety of protein–protein interaction assays, we identify DHX15 as the critical helicase. We further show that depletion of DHX15 or expression of any of several DHX15 mutants, including one implicated in acute myeloid leukemia, partially recapitulates the splicing defects of mutant SF3B1. Moreover, a DHX15-SUGP1 G-patch fusion protein is able to incorporate into the spliceosome to rescue the splicing defects of mutant SF3B1. We also present the crystal structure of the human DHX15-SUGP1 G-patch complex, which reveals the molecular basis of their direct interaction. Our data thus demonstrate that DHX15 is the RNA helicase that functions with SUGP1 and additionally provide important insight into how mutant SF3B1 disrupts splicing in cancer.
format Online
Article
Text
id pubmed-9894173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-98941732023-06-02 DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer Zhang, Jian Huang, Ji Xu, Ke Xing, Peiqi Huang, Yue Liu, Zhaoqi Tong, Liang Manley, James L. Proc Natl Acad Sci U S A Biological Sciences SF3B1 is the most frequently mutated spliceosomal gene in cancer. Several hotspot mutations are known to disrupt the interaction of SF3B1 with another splicing factor, SUGP1, resulting in the RNA missplicing that characterizes mutant SF3B1 cancers. Properties of SUGP1, especially the presence of a G-patch motif, a structure known to function by activating DEAH-box RNA helicases, suggest the requirement of such an enzyme in SUGP1 function in splicing. However, the identity of this putative helicase has remained an important unanswered question. Here, using a variety of protein–protein interaction assays, we identify DHX15 as the critical helicase. We further show that depletion of DHX15 or expression of any of several DHX15 mutants, including one implicated in acute myeloid leukemia, partially recapitulates the splicing defects of mutant SF3B1. Moreover, a DHX15-SUGP1 G-patch fusion protein is able to incorporate into the spliceosome to rescue the splicing defects of mutant SF3B1. We also present the crystal structure of the human DHX15-SUGP1 G-patch complex, which reveals the molecular basis of their direct interaction. Our data thus demonstrate that DHX15 is the RNA helicase that functions with SUGP1 and additionally provide important insight into how mutant SF3B1 disrupts splicing in cancer. National Academy of Sciences 2022-12-02 2022-12-06 /pmc/articles/PMC9894173/ /pubmed/36459648 http://dx.doi.org/10.1073/pnas.2216712119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Zhang, Jian
Huang, Ji
Xu, Ke
Xing, Peiqi
Huang, Yue
Liu, Zhaoqi
Tong, Liang
Manley, James L.
DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title_full DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title_fullStr DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title_full_unstemmed DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title_short DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer
title_sort dhx15 is involved in sugp1-mediated rna missplicing by mutant sf3b1 in cancer
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894173/
https://www.ncbi.nlm.nih.gov/pubmed/36459648
http://dx.doi.org/10.1073/pnas.2216712119
work_keys_str_mv AT zhangjian dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT huangji dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT xuke dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT xingpeiqi dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT huangyue dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT liuzhaoqi dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT tongliang dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer
AT manleyjamesl dhx15isinvolvedinsugp1mediatedrnamissplicingbymutantsf3b1incancer